Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes

Jenny E. Gunton, Rohit N. Kulkarni, SunHee Yim, Terumasa Okada, Wayne J. Hawthorne, Yu Hua Tseng, Russell S. Roberson, Camillo Ricordi, Philip J. O'Connell, Frank J. Gonzalez, C. Ronald Kahn

Research output: Contribution to journalArticlepeer-review

412 Scopus citations

Abstract

β cell dysfunction is a central component of the pathogenesis of type 2 diabetes. Using oligonucleotide microarrays and real-time PCR of pancreatic islets isolated from humans with type 2 diabetes versus normal glucose-tolerant controls, we identified multiple changes in expression of genes known to be important in β cell function, including major decreases in expression of HNF4α, insulin receptor, IRS2, Akt2, and several glucose-metabolic-pathway genes. There was also a 90% decrease in expression of the transcription factor ARNT. Reducing ARNT levels in Min6 cells with small interfering RNA (siRNA) resulted in markedly impaired glucose-stimulated insulin release and changes in gene expression similar to those in human type 2 islets. Likewise, β cell-specific ARNT knockout mice exhibited abnormal glucose tolerance, impaired insulin secretion, and changes in islet gene expression that mimicked those in human diabetic islets. Together, these data suggest an important role for decreased ARNT and altered gene expression in the impaired islet function of human type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)337-349
Number of pages13
JournalCell
Volume122
Issue number3
DOIs
StatePublished - Aug 12 2005

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes'. Together they form a unique fingerprint.

Cite this